43
Views
118
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Targeted Elimination of Peroxisome Proliferator-Activated Receptor γ in β Cells Leads to Abnormalities in Islet Mass without Compromising Glucose Homeostasis

, , , , , , , , , & show all
Pages 7222-7229 | Received 15 Jan 2003, Accepted 07 Jul 2003, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Hasan Zafe Acar, Oytun Okan Senel, Neslihan Bukan, Banu Yurekli, A Ebru Salman & Fahri Yetisir. (2013) Effects of rosiglitazone pretreatment on blood glucose, lipid levels, urea, and microalbuminuria in rats undergoing 70% pancreatectomy. Open Access Surgery 6, pages 1-5.
Read now
Koen M. A. Dreijerink, Radhika A. Varier, Olivier van Beekum, Ellen H. Jeninga, Jo W. M. Höppener, Cornelis J. M. Lips, J. Alain Kummer, Eric Kalkhoven & H. T. Marc Timmers. (2009) The Multiple Endocrine Neoplasia Type 1 (MEN1) Tumor Suppressor Regulates Peroxisome Proliferator-Activated Receptor γ-Dependent Adipocyte Differentiation. Molecular and Cellular Biology 29:18, pages 5060-5069.
Read now
Carmella Evans-Molina, Reiesha D. Robbins, Tatsuyoshi Kono, Sarah A. Tersey, George L. Vestermark, Craig S. Nunemaker, James C. Garmey, Tye G. Deering, Susanna R. Keller, Bernhard Maier & Raghavendra G. Mirmira. (2009) Peroxisome Proliferator-Activated Receptor γ Activation Restores Islet Function in Diabetic Mice through Reduction of Endoplasmic Reticulum Stress and Maintenance of Euchromatin Structure. Molecular and Cellular Biology 29:8, pages 2053-2067.
Read now
Mehboob A. Hussain, Delia L. Porras, Matthew H. Rowe, Jason R. West, Woo-Jin Song, Weston E. Schreiber & Fredric E. Wondisford. (2006) Increased Pancreatic β-Cell Proliferation Mediated by CREB Binding Protein Gene Activation. Molecular and Cellular Biology 26:20, pages 7747-7759.
Read now
Kathryn Aston-Mourney, Joseph Proietto & Sofianos Andrikopoulos. (2005) Investigational agents that protect pancreatic islet β-cells from failure. Expert Opinion on Investigational Drugs 14:10, pages 1241-1250.
Read now

Articles from other publishers (113)

Hoseong Hwang, Dahae Lee, Jong Dai Son, Jong Gwon Baek, Hyeon-Seong Lee, InWha Park, Dong Hoon Kim, Soon Kwang Lee, Won Kyu Kim, Hak Cheol Kwon, Ki Sung Kang & Jaeyoung Kwon. (2023) Chemical constituents isolated from Actinidia polygama and their α-glucosidase inhibitory activity and insulin secretion effect. Bioorganic Chemistry 134, pages 106466.
Crossref
Xiaojing Zhang, Baoyi Zhu, Peibin Lin, Xiaoping Liu, Jun Gao, Dazhong Yin, Jianwen Zeng, Baojian Liao & Zhanfang Kang. (2022) Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs. Frontiers in Endocrinology 13.
Crossref
Yue Zhao, Qing-Yu Wang, Lv-Tao Zeng, Jing-Jing Wang, Zhen Liu, Guo-Qing Fan, Jin Li & Jian-Ping Cai. (2022) Long-Term High-Fat High-Fructose Diet Induces Type 2 Diabetes in Rats through Oxidative Stress. Nutrients 14:11, pages 2181.
Crossref
Somayye Taghvaei & Leila Saremi. (2022) Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPARγ2 Associated with Type 2 Diabetes, Cardiovascular Disease, and Nonalcoholic Fatty Liver Disease. PPAR Research 2022, pages 1-10.
Crossref
Eiji Yoshihara. (2022) Adapting Physiology in Functional Human Islet Organogenesis. Frontiers in Cell and Developmental Biology 10.
Crossref
Leslie S. Satin, Scott A. Soleimanpour & Emily M. Walker. (2021) New Aspects of Diabetes Research and Therapeutic Development. Pharmacological Reviews 73:3, pages 1001-1015.
Crossref
Xue-Feng Li, Guang-Bin Jiang, Shi-Yan Cheng, Ya-Feng Song, Cai Deng, Yu-Ming Niu & Jun-Wei Cai. (2021) Association between PPAR-γ2 gene polymorphisms and diabetic retinopathy risk: a meta-analysis . Aging 13:4, pages 5136-5149.
Crossref
Jianwei Xiong, Peng Sun, Ya Wang, Xu Hua, Wenyu Song, Yan Wang, Jie Wu, Wenfeng Yu, George Liu & Ling Chen. (2019) Heterozygous deletion of Seipin in islet beta cells of male mice has an impact on insulin synthesis and secretion through reduced PPARγ expression. Diabetologia 63:2, pages 338-350.
Crossref
Adriana Ribeiro Silva, Cassiano Felippe Gonçalves-de-Albuquerque, Ana Rosa Pérez & Vinicius de Frias Carvalho. (2019) Immune-endocrine interactions related to a high risk of infections in chronic metabolic diseases: The role of PPAR gamma. European Journal of Pharmacology 854, pages 272-281.
Crossref
Federica Gilardi, Carine Winkler, Laure Quignodon, Jean-Gael Diserens, Barbara Toffoli, Mariano Schiffrin, Chiara Sardella, Frédéric Preitner & Béatrice Desvergne. (2019) Systemic PPARγ deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility. Metabolism 95, pages 8-20.
Crossref
Mark E Pepin, Hayden H Bickerton, Maigen Bethea, Chad S Hunter, Adam R Wende & Ronadip R Banerjee. (2019) Prolactin Receptor Signaling Regulates a Pregnancy-Specific Transcriptional Program in Mouse Islets. Endocrinology 160:5, pages 1150-1163.
Crossref
Min Jeong Kwon, Yong Jae Lee, Hye Sook Jung, Hyun Mi Shin, Tae Nyun Kim, Soon Hee Lee, Byoung Doo Rhee, Mi-kyung Kim & Jeong Hyun Park. (2019) The direct effect of lobeglitazone, a new thiazolidinedione, on pancreatic beta cells: A comparison with other thiazolidinediones. Diabetes Research and Clinical Practice 151, pages 209-223.
Crossref
Risheng Ye, Toshiharu Onodera & Philipp E Scherer. (2019) Lipotoxicity and β Cell Maintenance in Obesity and Type 2 Diabetes. Journal of the Endocrine Society 3:3, pages 617-631.
Crossref
Alpana Mukhuty, Chandrani Fouzder, Snehasis Das & Dipanjan Chattopadhyay. 2019. Type 2 Diabetes [Working Title]. Type 2 Diabetes [Working Title].
Marina O. Fernandez & Nicholas J.G. Webster. 2019. Molecular Nutrition: Carbohydrates. Molecular Nutrition: Carbohydrates 115 127 .
Risheng Ye, Ruth Gordillo, Mengle Shao, Toshiharu Onodera, Zhe Chen, Shiuhwei Chen, Xiaoli Lin, Jeffrey A. SoRelle, Xiaohong Li, Miao Tang, Mark P. Keller, Regina Kuliawat, Alan D. Attie, Rana K. Gupta, William L. Holland, Bruce Beutler, Joachim Herz & Philipp E. Scherer. (2018) Intracellular lipid metabolism impairs β cell compensation during diet-induced obesity. Journal of Clinical Investigation 128:3, pages 1178-1189.
Crossref
Seok-Woo Hong, Jinmi LeeJung Hwan ChoHyemi KwonSe Eun ParkEun-Jung RheeCheol-Young ParkKi-Won OhSung-Woo ParkWon-Young Lee. (2018) Pioglitazone Attenuates Palmitate-Induced Inflammation and Endoplasmic Reticulum Stress in Pancreatic β-Cells. Endocrinology and Metabolism 33:1, pages 105.
Crossref
Jens Werner & Stephan Herzig. 2018. Pancreatic Cancer. Pancreatic Cancer 633 657 .
Jens Werner & Stephan Herzig. 2017. Pancreatic Cancer. Pancreatic Cancer 1 25 .
E. D. Rosen. (2016) Epigenomic and transcriptional control of insulin resistance. Journal of Internal Medicine 280:5, pages 443-456.
Crossref
Ling L. Chia, Ibrahim Jantan, Kien H. Chua, Kok W. Lam, Kamal Rullah & Mohd F. M. Aluwi. (2016) Effects of Tocotrienols on Insulin Secretion-Associated Genes Expression of Rat Pancreatic Islets in a Dynamic Culture. Frontiers in Pharmacology 7.
Crossref
Peter E. O’Donnell, Xiu Zhen Ye, Melissa A. DeChellis, Vannessa M. Davis, Sheng Zhong Duan, Richard M. Mortensen & David S. Milstone. (2016) Lipodystrophy, Diabetes and Normal Serum Insulin in PPARγ-Deficient Neonatal Mice. PLOS ONE 11:8, pages e0160636.
Crossref
Attila Pap, Ixchelt Cuaranta-Monroy, Matthew Peloquin & Laszlo Nagy. (2016) Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?. International Journal of Molecular Sciences 17:8, pages 1236.
Crossref
Sona Kang, Linus T-Y. Tsai & Evan D. Rosen. (2016) Nuclear Mechanisms of Insulin Resistance. Trends in Cell Biology 26:5, pages 341-351.
Crossref
Elizabeth A. O'Hare, Laura M. Yerges-Armstrong, James A. Perry, Alan R. Shuldiner & Norann A. Zaghloul. (2016) Assignment of Functional Relevance to Genes at Type 2 Diabetes-Associated Loci Through Investigation of β-Cell Mass Deficits. Molecular Endocrinology 30:4, pages 429-445.
Crossref
Shuiling Zhao, Leo Ka Yu Chan, Lihua Chen, Tsz Wai Cheng, Thomas Klein & Po Sing Leung. (2016) Combination of Telmisartan and Linagliptin Preserves Pancreatic Islet Cell Function and Morphology in db/db Mice. Pancreas 45:4, pages 584-592.
Crossref
Xinyue Jing, Chen Ou, Hui Chen, Tianlin Wang, Bin Xu, Shengfeng Lu & Bing-Mei Zhu. (2016) Electroacupuncture Reduces Weight Gain Induced by Rosiglitazone through PPAR γ and Leptin Receptor in CNS . Evidence-Based Complementary and Alternative Medicine 2016, pages 1-12.
Crossref
Sukanya Lodh, Timothy L. Hostelley, Carmen C. Leitch, Elizabeth A. O'Hare & Norann A. Zaghloul. (2016) Differential effects on β-cell mass by disruption of Bardet–Biedl syndrome or Alstrom syndrome genes. Human Molecular Genetics 25:1, pages 57-68.
Crossref
Jessica R. Gooding, Mette V. Jensen & Christopher B. Newgard. (2016) Metabolomics applied to the pancreatic islet. Archives of Biochemistry and Biophysics 589, pages 120-130.
Crossref
Kenneth S. Polonsky & Charles F. Burant. 2016. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology 1385 1450 .
Carla Beatriz Collares-Buzato. 2016. Molecular Nutrition and Diabetes. Molecular Nutrition and Diabetes 115 130 .
W Y So, Q Cheng, A Xu, K S L Lam & P S Leung. (2015) Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice. Cell Death & Disease 6:3, pages e1707-e1707.
Crossref
Zuzana Papackova & Monika Cahova. (2015) Fatty Acid Signaling: The New Function of Intracellular Lipases. International Journal of Molecular Sciences 16:2, pages 3831-3855.
Crossref
K-Lynn N. Hogh, Michael N. Craig, Christopher E. Uy, Heli Nygren, Ali Asadi, Madeline Speck, Jordie D. Fraser, Alexander P. Rudecki, Robert K. Baker, Matej Orešič & Sarah L. Gray. (2014) Overexpression of PPARγ Specifically in Pancreatic β-Cells Exacerbates Obesity-Induced Glucose Intolerance, Reduces β-Cell Mass, and Alters Islet Lipid Metabolism in Male Mice. Endocrinology 155:10, pages 3843-3852.
Crossref
Raymond E. Soccio, Eric R. Chen & Mitchell A. Lazar. (2014) Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes. Cell Metabolism 20:4, pages 573-591.
Crossref
Amelia K. Linnemann, Mieke Baan & Dawn Belt Davis. (2014) Pancreatic β-Cell Proliferation in Obesity. Advances in Nutrition 5:3, pages 278-288.
Crossref
Z. Vergotine, A. P. Kengne, R. T. Erasmus, Y. Y. Yako & T. E. Matsha. (2014) Rare Mutations of Peroxisome Proliferator-Activated Receptor Gamma: Frequencies and Relationship with Insulin Resistance and Diabetes Risk in the Mixed Ancestry Population from South Africa. International Journal of Endocrinology 2014, pages 1-8.
Crossref
Tony Jourdan, Grzegorz Godlewski, Resat Cinar, Adeline Bertola, Gergő Szanda, Jie Liu, Joseph Tam, Tiffany Han, Bani Mukhopadhyay, Monica C Skarulis, Cynthia Ju, Myriam Aouadi, Michael P Czech & George Kunos. (2013) Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nature Medicine 19:9, pages 1132-1140.
Crossref
Dhananjay Gupta, Averi A. Leahy, Navjot Monga, Mina Peshavaria, Thomas L. Jetton & Jack L. Leahy. (2013) Peroxisome Proliferator-activated Receptor γ (PPARγ) and Its Target Genes Are Downstream Effectors of FoxO1 Protein in Islet β-Cells. Journal of Biological Chemistry 288:35, pages 25440-25449.
Crossref
Jordi Lanuza-Masdeu, M. Isabel Arévalo, Cristina Vila, Albert Barberà, Ramon Gomis & Carme Caelles. (2013) In Vivo JNK Activation in Pancreatic β-Cells Leads to Glucose Intolerance Caused by Insulin Resistance in Pancreas. Diabetes 62:7, pages 2308-2317.
Crossref
Maryam Ahmadian, Jae Myoung Suh, Nasun Hah, Christopher Liddle, Annette R Atkins, Michael Downes & Ronald M Evans. (2013) PPARγ signaling and metabolism: the good, the bad and the future. Nature Medicine 19:5, pages 557-566.
Crossref
An-ping Wang, Xia Li, Ying Zheng, Bi-lian Liu, Gan Huang, Xiang Yan, Zhenqi Liu & Zhiguang Zhou. (2010) Thiazolidinediones protect mouse pancreatic β-cells directly from cytokine-induced cytotoxicity through PPARγ-dependent mechanisms. Acta Diabetologica 50:2, pages 163-173.
Crossref
Yunxia Zhu, Ai Ma, Hongxiu Zhang & Chaojun Li. (2013) PPARγ Activation Attenuates Glycated-Serum Induced Pancreatic Beta-Cell Dysfunction through Enhancing Pdx1 and Mafa Protein Stability. PLoS ONE 8:2, pages e56386.
Crossref
Wenjun Xu, Jiahong Xu, Bing Sun, Haibin Chen, Yiping Wang, Feifei Huang, Peng Xi & Jinfa Jiang. (2012) The effect of PPARG gene polymorphisms on the risk of coronary heart disease: a meta-analysis. Molecular Biology Reports 40:2, pages 875-884.
Crossref
Hannah J. Welters, Abdelfattah El Ouaamari, Dan Kawamori, John Meyer, Jiang Hu, David M. Smith & Rohit N. Kulkarni. (2012) Rosiglitazone Promotes PPARγ-Dependent and -Independent Alterations in Gene Expression in Mouse Islets. Endocrinology 153:10, pages 4593-4599.
Crossref
Lars la Cour Poulsen, Majken Siersbæk & Susanne Mandrup. (2012) PPARs: Fatty acid sensors controlling metabolism. Seminars in Cell & Developmental Biology 23:6, pages 631-639.
Crossref
Gaetano Santulli, Angela Lombardi, Daniela Sorriento, Antonio Anastasio, Carmine Del Giudice, Pietro Formisano, Francesco Béguinot, Bruno Trimarco, Claudia Miele & Guido Iaccarino. (2012) Age-Related Impairment in Insulin Release. Diabetes 61:3, pages 692-701.
Crossref
Zhen Zeng, Bing Yu, Xiangbing Mao & Daiwen Chen. (2012) Effects of dietary digestible energy concentration on growth, meat quality, and PPARγ gene expression in muscle and adipose tissues of Rongchang piglets. Meat Science 90:1, pages 66-70.
Crossref
Yurena Vivas, Cristina Martínez-García, Adriana Izquierdo, Francisco Garcia-Garcia, Sergio Callejas, Ismael Velasco, Mark Campbell, Manuel Ros, Ana Dopazo, Joaquin Dopazo, Antonio Vidal-Puig & Gema Medina-Gomez. (2011) Early peroxisome proliferator-activated receptor gamma regulated genes involved in expansion of pancreatic beta cell mass. BMC Medical Genomics 4:1.
Crossref
Tamas Varga, Zsolt Czimmerer & Laszlo Nagy. (2011) PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1812:8, pages 1007-1022.
Crossref
Shigeki Sugii & Ronald M. Evans. (2011) Epigenetic codes of PPARγ in metabolic disease. FEBS Letters 585:13, pages 2121-2128.
Crossref
John B. Buse, Kenneth S. Polonsky & Charles F. Burant. 2011. Williams Textbook of Endocrinology. Williams Textbook of Endocrinology 1371 1435 .
D. Gupta, T. Kono & C. Evans-Molina. (2010) The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 12:12, pages 1036-1047.
Crossref
Martijn van de Bunt & Anna L. Gloyn. (2010) From Genetic Association to Molecular Mechanism. Current Diabetes Reports 10:6, pages 452-466.
Crossref
Avani A. PendseLance A. JohnsonYau-Sheng TsaiNobuyo Maeda. (2010) Pparg-P465L Mutation Worsens Hyperglycemia in Ins2-Akita Female Mice via Adipose-Specific Insulin Resistance and Storage Dysfunction . Diabetes 59:11, pages 2890-2897.
Crossref
Johanna K. DiStefano & Richard M. Watanabe. (2010) Pharmacogenetics of Anti-Diabetes Drugs. Pharmaceuticals 3:8, pages 2610-2646.
Crossref
S. Z. Duan, M. G. Usher, E. L. FoleyIVIV, D. S. Milstone, F. C. BrosiusIIIIII & R. M. Mortensen. (2010) Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-γ (PPAR-γ)-deficient mice. Diabetologia 53:7, pages 1493-1505.
Crossref
Anil KumarJohn C. LawrenceJr.Jr., Dae Young JungHwi Jin KoSusanna R. KellerJason K. Kim, Mark A. MagnusonThurl E. Harris. (2010) Fat Cell–Specific Ablation of Rictor in Mice Impairs Insulin-Regulated Fat Cell and Whole-Body Glucose and Lipid Metabolism . Diabetes 59:6, pages 1397-1406.
Crossref
Yukiko Kanda, Masashi Shimoda, Sumiko Hamamoto, Kazuhito Tawaramoto, Fumiko Kawasaki, Mitsuru Hashiramoto, Koji Nakashima, Michihiro Matsuki & Kohei Kaku. (2010) Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist. American Journal of Physiology-Endocrinology and Metabolism 298:2, pages E278-E286.
Crossref
John P. Neoptolemos, Raul Urrutia, James L. Abbruzzese & Markus W. BüchlerJens Werner & Stephan Herzig. 2010. Pancreatic Cancer. Pancreatic Cancer 651 673 .
S Schinner, R Krätzner, D Baun, C Dickel, R Blume & E Oetjen. (2009) Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor γ and thiazolidinedione oral antidiabetic drugs. British Journal of Pharmacology 157:5, pages 736-745.
Crossref
Jack L. Leahy. (2009) Thiazolidinediones in prediabetes and early type 2 diabetes: What can be learned about that disease’s pathogenesis. Current Diabetes Reports 9:3, pages 215-220.
Crossref
Caroline Fernandes-Santos, Rafael Evangelista Carneiro, Leonardo de Souza Mendonca, Márcia Barbosa Águila & Carlos Alberto Mandarim-de-Lacerda. (2009) Rosiglitazone Aggravates Nonalcoholic Fatty Pancreatic Disease in C57BL/6 Mice Fed High-Fat and High-Sucrose Diet. Pancreas 38:3, pages e80-e86.
Crossref
M. Akiyama, M. Hatanaka, Y. Ohta, K. Ueda, A. Yanai, Y. Uehara, K. Tanabe, M. Tsuru, M. Miyazaki, S. Saeki, T. Saito, K. Shinoda, Y. Oka & Y. Tanizawa. (2009) Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice. Diabetologia 52:4, pages 653-663.
Crossref
David A. Sarruf, Fang Yu, Hong T. Nguyen, Diana L. Williams, Richard L. Printz, Kevin D. Niswender & Michael W. Schwartz. (2009) Expression of Peroxisome Proliferator-Activated Receptor-γ in Key Neuronal Subsets Regulating Glucose Metabolism and Energy Homeostasis. Endocrinology 150:2, pages 707-712.
Crossref
Luis VillacortaFrancisco J. SchopferJifeng ZhangBruce A. FreemanY. Eugene Chen. (2009) PPARγ and its ligands: therapeutic implications in cardiovascular disease. Clinical Science 116:3, pages 205-218.
Crossref
Dhananjay Gupta, Thomas L. Jetton, Richard M. Mortensen, Sheng Zhong Duan, Mina Peshavaria & Jack L. Leahy. (2008) In Vivo and in Vitro Studies of a Functional Peroxisome Proliferator-activated Receptor γ Response Element in the Mouse pdx-1 Promoter. Journal of Biological Chemistry 283:47, pages 32462-32470.
Crossref
Zhao V. Wang, James Mu, Todd D. Schraw, Laurent Gautron, Joel K. Elmquist, Bei B. Zhang, Michael Brownlee & Philipp E. Scherer. (2008) PANIC-ATTAC: A Mouse Model for Inducible and Reversible β-Cell Ablation. Diabetes 57:8, pages 2137-2148.
Crossref
Lydia Aguilar-Bryan & Joseph Bryan. (2008) Neonatal Diabetes Mellitus. Endocrine Reviews 29:3, pages 265-291.
Crossref
Ralph Krätzner, Florian Fröhlich, Katrin Lepler, Michaela Schröder, Katharina Röher, Corinna Dickel, Mladen V. Tzvetkov, Thomas Quentin, Elke Oetjen & Willhart Knepel. (2008) A Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor Heterodimer Physically Interacts with the Transcriptional Activator PAX6 to Inhibit Glucagon Gene Transcription. Molecular Pharmacology 73:2, pages 509-517.
Crossref
William D. Rees, Christopher J. McNeil & Christopher A. Maloney. (2008) The Roles of PPARs in the Fetal Origins of Metabolic Health and Disease. PPAR Research 2008, pages 1-8.
Crossref
C. Y. Ivashchenko, S. Z. Duan, M. G. Usher & R. M. Mortensen. (2007) PPAR-γ knockout in pancreatic epithelial cells abolishes the inhibitory effect of rosiglitazone on caerulein-induced acute pancreatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 293:1, pages G319-G326.
Crossref
Ian W. Campbell & Segundo Mariz. (2007) β-Cell preservation with thiazolidinediones. Diabetes Research and Clinical Practice 76:2, pages 163-176.
Crossref
Gema Medina-Gomez, Sarah L Gray, Laxman Yetukuri, Kenju Shimomura, Sam Virtue, Mark Campbell, R. Keira Curtis, Mercedes Jimenez-Linan, Margaret Blount, Giles S. H Yeo, Miguel Lopez, Tuulikki Seppänen-Laakso, Frances M Ashcroft, Matej Orešič & Antonio Vidal-Puig. (2007) PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism. PLoS Genetics 3:4, pages e64.
Crossref
Effie Tozzo, Randolph Ponticiello, JoAnn Swartz, Dennis Farrelly, Rachel Zebo, Gustav Welzel, Donald Egan, Lori Kunselman, Andrew Peters, Liqun Gu, Michele French, Sean Chen, Pratik Devasthale, Evan Janovitz, Ada Staal, Thomas Harrity, Rene Belder, Peter T. Cheng, Jean Whaley, Simeon Taylor & Narayanan Hariharan. (2007) The Dual Peroxisome Proliferator-Activated Receptor α/γ Activator Muraglitazar Prevents the Natural Progression of Diabetes in db/db Mice . Journal of Pharmacology and Experimental Therapeutics 321:1, pages 107-115.
Crossref
Sheng Zhong Duan, Christine Y. Ivashchenko, Steven E. Whitesall, Louis G. D’Alecy, Damon C. Duquaine, Frank C. BrosiusIIIIII, Frank J. Gonzalez, Charles Vinson, Melissa A. Pierre, David S. Milstone & Richard M. Mortensen. (2007) Hypotension, lipodystrophy, and insulin resistance in generalized PPARγ-deficient mice rescued from embryonic lethality. Journal of Clinical Investigation 117:3, pages 812-822.
Crossref
Amalia Gastaldelli, Ele Ferrannini, Yoshinori Miyazaki, Masafumi Matsuda, Andrea Mari & Ralph A. DeFronzo. (2007) Thiazolidinediones improve β-cell function in type 2 diabetic patients. American Journal of Physiology-Endocrinology and Metabolism 292:3, pages E871-E883.
Crossref
Jacob A. Moibi, Dhananjay Gupta, Thomas L. Jetton, Mina Peshavaria, Ronak Desai & Jack L. Leahy. (2007) Peroxisome Proliferator–Activated Receptor-γ Regulates Expression of PDX-1 and NKX6.1 in INS-1 Cells. Diabetes 56:1, pages 88-95.
Crossref
Yaacov Barak & Suyeon Kim. (2007) Genetic Manipulations of PPARs: Effects on Obesity and Metabolic Disease. PPAR Research 2007, pages 1-12.
Crossref
H. H. Bock, J. Herz & P. May. 2007. Conditional Mutagenesis: An Approach to Disease Models. Conditional Mutagenesis: An Approach to Disease Models 407 439 .
Thomas Barz, Anke Hoffmann, Markus Panhuysen & Dietmar Spengler. (2006) Peroxisome Proliferator-Activated Receptor γ Is a Zac Target Gene Mediating Zac Antiproliferation. Cancer Research 66:24, pages 11975-11982.
Crossref
Liliane Michalik, Johan Auwerx, Joel P. Berger, V. Krishna Chatterjee, Christopher K. Glass, Frank J. Gonzalez, Paul A. Grimaldi, Takashi Kadowaki, Mitchell A. Lazar, Stephen O'Rahilly, Colin N. A. Palmer, Jorge Plutzky, Janardan K. Reddy, Bruce M. Spiegelman, Bart Staels & Walter Wahli. (2006) International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors. Pharmacological Reviews 58:4, pages 726-741.
Crossref
Fan Zhang, Åke Sjöholm & Qimin Zhang. (2006) Pioglitazone acutely influences glucose-sensitive insulin secretion in normal and diabetic human islets. Biochemical and Biophysical Research Communications 351:3, pages 750-755.
Crossref
Mitsugu Yamanaka, Yasushi Itakura, Tadashi Inoue, Atsushi Tsuchida, Tsutomu Nakagawa, Hiroshi Noguchi & Mutsuo Taiji. (2006) Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice. Metabolism 55:10, pages 1286-1292.
Crossref
Ryosuke Nakano, Eiji Kurosaki, Shigeru Yoshida, Masanori Yokono, Akiyoshi Shimaya, Tatsuya Maruyama & Masayuki Shibasaki. (2006) Antagonism of peroxisome proliferator-activated receptor γ prevents high-fat diet-induced obesity in vivo. Biochemical Pharmacology 72:1, pages 42-52.
Crossref
Béatrice Desvergne, Liliane Michalik & Walter Wahli. (2006) Transcriptional Regulation of Metabolism. Physiological Reviews 86:2, pages 465-514.
Crossref
Tuomo Rankinen, Aamir Zuberi, Yvon C. Chagnon, S. John Weisnagel, George Argyropoulos, Brandon Walts, Louis Pérusse & Claude Bouchard. (2006) The Human Obesity Gene Map: The 2005 Update. Obesity 14:4, pages 529-644.
Crossref
Ji-Yeon Lee, Michael Ristow, Xueying Lin, Morris F. White, Mark A. Magnuson & Lothar Hennighausen. (2006) RIP-Cre Revisited, Evidence for Impairments of Pancreatic β-Cell Function. Journal of Biological Chemistry 281:5, pages 2649-2653.
Crossref
N. Neubauer & R. N. Kulkarni. (2006) Molecular Approaches to Study Control of Glucose Homeostasis. ILAR Journal 47:3, pages 199-211.
Crossref
S.L. GrayE. Dalla NoraA.J. Vidal-Puig. (2005) Mouse models of PPAR-γ deficiency: dissecting PPAR-γ's role in metabolic homoeostasis. Biochemical Society Transactions 33:5, pages 1053-1058.
Crossref
Christopher A Maloney & William D Rees. (2005) Gene-nutrient interactions during fetal development. Reproduction 130:4, pages 401-410.
Crossref
Cecilie Kjørholt, Mia C. Åkerfeldt, Trevor J. Biden & D. Ross Laybutt. (2005) Chronic Hyperglycemia, Independent of Plasma Lipid Levels, Is Sufficient for the Loss of β-Cell Differentiation and Secretory Function in the db/db Mouse Model of Diabetes . Diabetes 54:9, pages 2755-2763.
Crossref
Kim Ravnskjaer, Michael Boergesen, Blanca Rubi, Jan K. Larsen, Tina Nielsen, Jakob Fridriksson, Pierre Maechler & Susanne Mandrup. (2005) Peroxisome Proliferator-Activated Receptor α (PPARα) Potentiates, whereas PPARγ Attenuates, Glucose-Stimulated Insulin Secretion in Pancreatic β-Cells. Endocrinology 146:8, pages 3266-3276.
Crossref
Subbaya Subramanian, Robert B West, Robert J Marinelli, Torsten O Nielsen, Brian P Rubin, John R Goldblum, Rajiv M Patel, Shirley Zhu, Kelli Montgomery, Tony L Ng, Christopher L Corless, Michael C Heinrich & Matt van de Rijn. (2005) The gene expression profile of extraskeletal myxoid chondrosarcoma. The Journal of Pathology 206:4, pages 433-444.
Crossref
H. Poirier, C. Rouault, L. Clément, I. Niot, M.-C. Monnot, M. Guerre-Millo & P. Besnard. (2005) Hyperinsulinaemia triggered by dietary conjugated linoleic acid is associated with a decrease in leptin and adiponectin plasma levels and pancreatic beta cell hyperplasia in the mouse. Diabetologia 48:6, pages 1059-1065.
Crossref
Jessica Costa-Guda, Evan D. Rosen, Robert T. Jensen, Daniel C. Chung & Andrew Arnold. (2005) Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours. Clinical Endocrinology 62:5, pages 603-606.
Crossref
Julie R. Jones, Cordelia Barrick, Kyoung-Ah Kim, Jill Lindner, Bertrand Blondeau, Yuka Fujimoto, Masakazu Shiota, Robert A. Kesterson, Barbara B. Kahn & Mark A. Magnuson. (2005) Deletion of PPARγ in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proceedings of the National Academy of Sciences 102:17, pages 6207-6212.
Crossref
Hélène Bihan, Christine Rouault, Gérard Reach, Vincent Poitout, Bart Staels & Michèle Guerre-Millo. (2005) Pancreatic islet response to hyperglycemia is dependent on peroxisome proliferator-activated receptor alpha (PPARα). FEBS Letters 579:11, pages 2284-2288.
Crossref
D. A. Rees & J. C. Alcolado. (2005) Animal models of diabetes mellitus. Diabetic Medicine 22:4, pages 359-370.
Crossref
Bethany D. Freedman, Eun-Jig Lee, Youngkyu Park & J. Larry Jameson. (2005) A Dominant Negative Peroxisome Proliferator-activated Receptor-γ Knock-in Mouse Exhibits Features of the Metabolic Syndrome. Journal of Biological Chemistry 280:17, pages 17118-17125.
Crossref
M Bouskila, U B Pajvani & P E Scherer. (2005) Adiponectin: a relevant player in PPARγ-agonist-mediated improvements in hepatic insulin sensitivity?. International Journal of Obesity 29:S1, pages S17-S23.
Crossref
Louis Pérusse, Tuomo Rankinen, Aamir Zuberi, Yvon C. Chagnon, S. John Weisnagel, George Argyropoulos, Brandon Walts, Eric E. Snyder & Claude Bouchard. (2005) The Human Obesity Gene Map: The 2004 Update. Obesity Research 13:3, pages 381-490.
Crossref
C. A. Argmann, T.-A. Cock & J. Auwerx. (2005) Peroxisome proliferator-activated receptor gamma: the more the merrier?. European Journal of Clinical Investigation 35:2, pages 82-92.
Crossref
H. Poirier, I. Niot, L. Clément, M. Guerre-Millo & P. Besnard. (2005) Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse. Biochimie 87:1, pages 73-79.
Crossref
Jean-Claude Henquin. (2004) Pathways in Beta-Cell Stimulus-Secretion Coupling as Targets for Therapeutic Insulin Secretagogues. Diabetes 53:suppl_3, pages S48-S58.
Crossref
Chris Knouff & Johan Auwerx. (2004) Peroxisome Proliferator-Activated Receptor-γ Calls for Activation in Moderation: Lessons from Genetics and Pharmacology. Endocrine Reviews 25:6, pages 899-918.
Crossref
Alex S.F. DoneyBettina FischerGraham LeeseAndrew D. MorrisColin N.A. Palmer. (2004) Cardiovascular Risk in Type 2 Diabetes Is Associated With Variation at the PPARG Locus . Arteriosclerosis, Thrombosis, and Vascular Biology 24:12, pages 2403-2407.
Crossref
Junji Matsui, Yasuo Terauchi, Naoto Kubota, Iseki Takamoto, Kazuhiro Eto, Tokuyuki Yamashita, Kajuro Komeda, Toshimasa Yamauchi, Junji Kamon, Shunbun Kita, Mitsuhiko Noda & Takashi Kadowaki. (2004) Pioglitazone Reduces Islet Triglyceride Content and Restores Impaired Glucose-Stimulated Insulin Secretion in Heterozygous Peroxisome Proliferator–Activated Receptor-γ–Deficient Mice on a High-Fat Diet. Diabetes 53:11, pages 2844-2854.
Crossref
E. Zeender, K. Maedler, D. Bosco, T. Berney, M. Y. Donath & P. A. Halban. (2004) Pioglitazone and Sodium Salicylate Protect Human β-Cells against Apoptosis and Impaired Function Induced by Glucose and Interleukin-1β. The Journal of Clinical Endocrinology & Metabolism 89:10, pages 5059-5066.
Crossref
Laura E. Parton, Frédérique Diraison, Suzanne E. Neill, Sujoy K. Ghosh, Mark A. Rubino, John E. Bisi, Celia P. Briscoe & Guy A. Rutter. (2004) Impact of PPARγ overexpression and activation on pancreatic islet gene expression profile analyzed with oligonucleotide microarrays. American Journal of Physiology-Endocrinology and Metabolism 287:3, pages E390-E404.
Crossref
Makoto Miyazaki, Agnieszka Dobrzyn, Harini Sampath, Seong-Ho Lee, Weng Chi Man, Kiki Chu, Jeffrey M. Peters, Frank J. Gonzalez & James M. Ntambi. (2004) Reduced Adiposity and Liver Steatosis by Stearoyl-CoA Desaturase Deficiency Are Independent of Peroxisome Proliferator-activated Receptor-α. Journal of Biological Chemistry 279:33, pages 35017-35024.
Crossref
Hannah J Welters, Stuart C McBain, Moh Tadayyon, John H B Scarpello, Stephen A Smith & Noel G Morgan. (2004) Expression and functional activity of PPAR γ in pancreatic β cells . British Journal of Pharmacology 142:7, pages 1162-1170.
Crossref
Terrie‐Anne Cock, Sander M Houten & Johan Auwerx. (2004) Peroxisome proliferator‐activated receptor‐γ: too much of a good thing causes harm. EMBO reports 5:2, pages 142-147.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.